0000950170-24-029523.txt : 20240311
0000950170-24-029523.hdr.sgml : 20240311
20240311194336
ACCESSION NUMBER: 0000950170-24-029523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Anthony
CENTRAL INDEX KEY: 0001606030
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 24739797
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
ownership.xml
4
X0508
4
2024-03-08
0000730272
REPLIGEN CORP
RGEN
0001606030
Hunt Anthony
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
false
true
false
false
Chief Executive Officer
true
Common Stock
2024-03-08
4
M
false
1
16.55
A
201956
D
Common Stock
2024-03-08
4
S
false
3377
195.49
D
198579
D
Common Stock
2024-03-08
4
S
false
6228
196.32
D
192351
D
Common Stock
2024-03-08
4
S
false
1666
197.39
D
190685
D
Common Stock
2024-03-08
4
S
false
1347
198.55
D
189338
D
Common Stock
2024-03-08
4
S
false
1822
199.53
D
187516
D
Common Stock
2024-03-08
4
S
false
1305
200.56
D
186211
D
Common Stock
2024-03-08
4
S
false
806
201.75
D
185405
D
Common Stock
2024-03-08
4
S
false
156
202.55
D
185249
D
Stock Option (Right to Buy)
16.55
2024-03-08
4
M
false
1
0.00
A
2024-05-05
Common Stock
1
0
D
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 9, 2023.
$195.49 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.90 to $195.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$196.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.95 to $196.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$197.39 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.98 to $197.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$198.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.05 to $198.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$199.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.13 to $200.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$200.56 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.18 to $200.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$201.75 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.21 to $202.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$202.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $202.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is fully vested and exercisable.
/s/ Kimberly Brown (Attorney in Fact)
2024-03-11